Jpmorgan Chase & CO Tandem Diabetes Care Inc Call Options Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding TNDM
# of Institutions
360Shares Held
72.5MCall Options Held
3.36MPut Options Held
229K-
Black Rock Inc. New York, NY11.1MShares$343 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.36MShares$227 Million0.01% of portfolio
-
Capital World Investors Los Angeles, CA3.27MShares$101 Million0.02% of portfolio
-
State Street Corp Boston, MA2.66MShares$81.8 Million0.0% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO2.39MShares$73.5 Million1.44% of portfolio
About TANDEM DIABETES CARE INC
- Ticker TNDM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 64,221,200
- Market Cap $1.98B
- Description
- Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...